Search Orphan Drug Designations and Approvals
-
| Generic Name: | MAGE-A3 cancer therapeutic Trojan peptide vaccine |
|---|---|
| Date Designated: | 11/24/2008 |
| Orphan Designation: | Treatment of MAGE-A3 expressing head and neck squamous cell carcinoma |
| Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Gliknik, Inc. 801 W. Baltimore Street Suite 501A Baltimore, Maryland 21201 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







